Founded with a commitment to advancing biological research, AbboMax Inc. is a pharmaceutical company specializing in immunohistochemistry and antibody production. The company's core mission is to develop high-quality biological products and provide professional custom services that enhance research and improve people's quality of life. AbboMax offers a range of products including antibodies, peptides, IHC/ISH kits, and assay products, targeting researchers and institutions in the biomedical field.
AbboMax has garnered attention for its innovative contributions to the pharmaceutical industry, particularly in the development of SARS-CoV-2 related products. The company is supported by a team of experienced scientists and has established a reputation for high product quality and customer satisfaction. Through its specialized offerings and customer-focused approach, AbboMax has made a significant impact on both research advancements and practical applications in healthcare.
